BOC Sciences liposome platform uses the latest microfluidics technology and achieves liposome protection of functional siRNA, shRNA, miRNA, mRNA, plasmid DNA, and protein molecules, providing uniform target particle size and enhancing in vivo delivery efficiency. We design the optimal size for each liposome to ensure the correct release of active ingredients into cells in the body. We use different liposomes to accommodate different delivery routes (topical, oral, pulmonary or parenteral).

Customers should provide a liposome-encapsulated dose of at least 0.25 mg. We deliver encapsulated liposome products to customers in sterile vials to ensure consistency and eliminate potential contamination.

https://liposomes.bocsci.com/solution/liposome-encapsulation-services-sirna-mirna-dna-proteins.html